Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
about
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyOptimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 womenComparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 GroupComparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture.Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia.A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusionsComparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma.A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus.Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement.Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detectionInclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.Simultaneous amplification and identification of 25 human papillomavirus types with Templex technologyAgreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa RicaA novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reactionPerformance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types.Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.The laboratory diagnosis of genital human papillomavirus infections.The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.Laboratory and clinical aspects of human papillomavirus testingCan clinical tests help monitor human papillomavirus vaccine impact?Human papillomavirus infections in primary careHuman papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenNegative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.Human papillomavirus genotype specificity of hybrid capture 2Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV typesHuman papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women.Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
P2860
Q30651813-BE374831-DCD1-4EA8-A6BB-A8934F3984FEQ33518244-85C64FB9-5419-48F5-88E1-D66E9D5ECEE7Q33533452-DB142A35-1E11-4D28-BB52-469BD9ED4ADBQ33885141-64108F6C-16CA-40AA-B147-319BE11F5ED8Q33954107-0D5DC013-0F59-48BE-B0A9-72BC71A67BAEQ33965378-1A283A00-D8DB-497F-B42B-19E0FF74EE62Q33974944-CBEF7E36-47D7-41CE-80B9-B4C1EED869E0Q34005026-97AF49A0-9CA0-4319-A10B-4FA6816893DEQ34208521-D41D6A8F-9E6F-48C0-B437-3782C5FE32FCQ34459447-FC2EA6DE-77EF-4C32-80EC-DF9ADB2E1915Q34680765-777C4A41-32A0-489F-8779-6671BBB26E46Q34719578-C1AEFE69-76BD-4246-88BC-D3DBCB3CBC03Q34773451-0921E441-BFB8-45CF-988B-049995BD2207Q34783310-614E6654-9168-44ED-8F24-0353DA4DA1C0Q35066537-92ACEA42-64F5-46E1-9C7C-24F997881FDBQ35138635-2FB060B0-4D37-43CD-8119-E2CF9C5325D3Q35220805-AE05AF33-6A12-4068-BA2F-495054034283Q35690377-D46AFE24-FC33-41C5-9317-82600E94C9BCQ35690441-18963A5B-C0F9-4305-ABBE-BBA859AA57D0Q35784544-F9BCCDC4-FC31-4352-8273-04C08F7BF1B0Q35788372-4CBFE618-6D4B-420A-BB26-E6688E55F89DQ35789716-F8D39BBD-9D60-4988-ADF6-70435A3F527EQ35913775-9F901991-3CA0-4F4D-825F-7742D4BC88C5Q35922890-AC2E50EF-061D-4ABF-A890-D4F26A428853Q36171005-54144646-B617-48B2-969A-4C61A07B1ED7Q36173887-0CC8ED93-7B32-4E70-8051-D6C196A4A30EQ36249128-93B9A55F-8144-449D-98FF-C40442BFD333Q36311573-30317FBD-861E-49AA-B953-5FB0B46CF21CQ36407727-3EE48A5E-55DE-4B49-9691-785FB3C605C7Q36510632-405DC3EE-7941-4BA0-8D7A-EB9C57811B7BQ36622396-1963616C-2C3B-4DA1-9175-33DAE2A56CE9Q36695105-B18196D9-DEB7-475C-A5AF-B3F5223C5AC4Q36845399-73BEBDF4-1655-45DF-9C8C-9CBD3EC6A8C4Q37295681-E6D81423-1AE1-40DF-87A4-B249F9F1080CQ37302193-237A34A0-2D7C-467E-AC80-B887710B9969Q37340546-200AB9C8-9150-4A88-9F1B-8D7F5D8D3BC3Q55424101-45EE173C-C4C3-458C-AF71-99154BB89486
P2860
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@ast
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@en
type
label
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@ast
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@en
prefLabel
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@ast
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@en
P2093
P2860
P1476
Comparison of PCR- and hybrid ...... pecimen collection strategies.
@en
P2093
A C Rodriguez
A Hildesheim
A T Lörincz
C L Peyton
C M Wheeler
I Mielzynska
L A Morera
M E Sherman
M Schiffman
P2860
P304
P407
P577
1998-11-01T00:00:00Z